VCAM1 and atherosclerosis: First, reduced surface levels of several adhesion molecules, with decreased monocyte (subset) adhesion to vascular cell adhesion molecule-1, after LSFD is expected to decrease monocyte infiltration into arterial walls and may therefore decelerate atherosclerosis progression.